7-year Follow-Up Outcomes after Stereotactic Ablation Radiotherapy for Stage I NSCLC: Results of a Phase Π Clinical Trial

BACKGROUND: We evaluated the efficacy, pattern of failure, and toxicity of stereotactic ablative radiotherapy (SABR) for medically inoperable clinical stage I non-small cell lung cancer (NSCLC) in a prospective clinical trial with 7 years follow-up. METHODS: Eligible patients with histologically con...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer
Main Authors: Sun, Bing, Brooks, Eric D., Komaki, Ritsuko, Liao, Zhongxing, Jeter, Melenda, McAleer, Mary, Allen, Pamela K., Balter, Peter A., Welsh, James D., O’Reilly, Michael, Gomez, Daniel, Hahn, Stephen. M., Roth, Jack A., Mehran, Reza J., Heymach, John V., Chang, Joe Y.
Formato: Artigo
Idioma:Inglês
Publicado: 2017
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5544582/
https://ncbi.nlm.nih.gov/pubmed/28346656
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30693
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares